ParentsTEGSNCT07022392
Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents
A study testing Technology-enhanced gender support platform in people with Parents and Usability, run by Seattle Children's Hospital at 1 site in United States.
Trial summary
This is a small pilot feasibility and acceptability study of implementing a Technology-Enhanced Gender Support (TEGS) platform with parents and caregivers. Parents and caregivers who consent to participate will complete an electronic survey at baseline. Read more about this study
- Who is it for?
- Ages 18 years and older
- What is being tested?
- Technology-enhanced gender support platform
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2025to 31 Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Parent of a gender diverse youth aged 8-17
- Has access to the internet
- Can speak or read English
Who cannot join
- Not a parent of a gender diverse youth aged 8-17
- No access to the internet
- Cannot speak or read in English
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Seattle Children's Hospital
Seattle, Washington, 98105
Gina Sequeira, MD, MS, 206-987-2028, gina.sequeira@seattlechildrens.org
Laura Richardson, MD, MPH, 206-987-2028, laura.richardson@seattlechildrens.org
About this study
Official title: Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation
This is a small pilot feasibility and acceptability study of implementing a Technology-Enhanced Gender Support (TEGS) platform with parents and caregivers. Parents and caregivers who consent to participate will complete an electronic survey at baseline. They will then receive access to the TEGS platform and complete follow up surveys 1 mo and 3 mo after. Each participant will also be given the option to participate in an exit interview.
- Being tested
- Technology-enhanced gender support platform
- Keywords
- parents
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Technology-enhanced gender support platformOther
Technology-based platform to support parents
| Study group | Role | What they receive |
|---|---|---|
| Technology-Enhanced Gender Support Platform | Experimental | Not described Receives: Other: Technology-enhanced gender support platform |
What is being measured
The primary outcome is the main question the study is designed to answer.
System Usability Scale
10 item measure of intervention usability measured on a scale from 0 to 100 with 100 indicating higher usability
Measured: 1 month and 3 months
Secondary outcomes (1)
Transgender Family Acceptance To Empowerment scale
16 item measure of parental acceptance and empowerment, measured on a scale of 0 to 80 with 80 indicating a better outcome
Measured: Baseline, 1 month, 3 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jun 2025
- Study start1 Oct 2025 (estimated)
- Primary completion1 Mar 2026 (estimated)
- Study completion31 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ParentsStudies of the same condition, open and under way.
- More trials run by Seattle Children's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- All parents and caregivers who agree to participate in the study will receive the same intervention- the TEGS platform. Each will complete surveys at baseline, 1 mo and 3mo after getting access to the platform.
- Masking
- None (open label)
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Seattle Children's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gina Sequeira, Seattle Children's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07022392
- Sponsor's protocol ID
- STUDY00005068
- Other IDs
- K08HS029028-01
- Acronym
- TEGS
- Status last verified
- Jun 2025
- First submitted
- 6 Jun 2025
- Last updated
- 24 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation
- ClinicalTrials.gov ID
- NCT07022392
- Acronym / sponsor ID
- TEGS / STUDY00005068
- Keywords
- parents
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Seattle Children's HospitalUniversity, hospital or other
- Study start
- 1 Oct 2025 (estimated)
- Primary completion
- 1 Mar 2026 (estimated)
- Study completion
- 31 Mar 2026 (estimated)
- First posted
- 15 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a small pilot feasibility and acceptability study of implementing a Technology-Enhanced Gender Support (TEGS) platform with parents and caregivers. Parents and caregivers who consent to participate will complete an electronic survey at baseline. They will then receive access to the TEGS platform and complete follow up surveys 1 mo and 3 mo after. Each participant will also be given the option to participate in an exit interview.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- All parents and caregivers who agree to participate in the study will receive the same intervention- the TEGS platform. Each will complete surveys at baseline, 1 mo and 3mo after getting access to the platform.
| Arm | Type | Receives |
|---|---|---|
| Technology-Enhanced Gender Support Platform | Experimental | Other: Technology-enhanced gender support platform |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Parent of a gender diverse youth aged 8-17
- Has access to the internet
- Can speak or read English
Key exclusion criteria (3 listed)
- Not a parent of a gender diverse youth aged 8-17
- No access to the internet
- Cannot speak or read in English
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Technology-enhanced gender support platformTechnology-based platform to support parents | Other | Technology-Enhanced Gender Support Platform |
Primary outcome
System Usability Scale
Time frame: 1 month and 3 months
10 item measure of intervention usability measured on a scale from 0 to 100 with 100 indicating higher usability
1 secondary outcome
Transgender Family Acceptance To Empowerment scale
Time frame: Baseline, 1 month, 3 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Parents
Active, not recruiting
Pediatric Parenting Support in Flint
Healthy, Family Research
Enrolling by invitation
MIO-CPP to Improve the Well-being, Permanency, and Safety Outcomes for Young Children at Risk of or in Out-of-home Placement in Philadelphia and Bucks Counties, and Affected by Maternal Substance Use
Substance Use Disorders, Parent-Child Relations
RecruitingObservational study
Pediatric Research in the Outpatient Setting CoHort
Factors Associated With a Child's Development of Interaction and Communication Skills and Measures Taken, Reported Stress Level of the Parents of a Newborn and Measures Taken
Recruiting
Effect of Support for Low-Income Mothers of Preterm Infants
Preterm Birth, Low; Birthweight, Extremely (999 Grams or Less)
Active, not recruiting
The Maternal Health Multilevel Intervention for Racial Equity (MIRACLE) Project
Maternal Morbidity and Mortality, Health Disparities
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Technology-enhanced gender support platform in people with Parents and Usability, run by Seattle Children's Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Gina Sequeira (206-987-2028, scgcresearch@seattlechildrens.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
System Usability Scale (time frame: 1 month and 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2025.